ArticleCell death & disease2024

Nose-to-brain selective drug delivery to glioma via ferritin-based nanovectors reduces tumor growth and improves survival rate.

Francesco Marrocco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.